Neurological adverse effects caused by cytotoxic and targeted therapies.
about
Microtubule-binding agents: a dynamic field of cancer therapeutics.Understanding, recognizing, and managing toxicities of targeted anticancer therapies.Herbal medicines and chemotherapy induced peripheral neuropathy (CIPN): A critical literature review.Metformin inhibits growth of human glioblastoma cells and enhances therapeutic responseNeurologic complications of cancer and its treatment.Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end?Chemotherapy-induced peripheral neurotoxicity (CIPN): what we need and what we know.Current use of drugs affecting the central nervous system for chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review.Macrophages as Active Nanocarriers for Targeted Early and Adjuvant Cancer Chemotherapy.An Overview of Bortezomib-Induced NeurotoxicityNo role for melanoma treatment in the association between melanoma and amyotrophic lateral sclerosis or Parkinson's disease.Bevacizumab in combination with sequential high-dose chemotherapy in solid cancer, a feasibility study.Deaths reported from the accidental intrathecal administration of bortezomib.Central neurotoxicity of standard treatment in patients with newly-diagnosed high-grade glioma: a prospective longitudinal study.Bcl-2 homology domain 3-only proteins Puma and Bim mediate the vulnerability of CA1 hippocampal neurons to proteasome inhibition in vivo.Cardiac autonomic functioning is impaired among allogeneic hematopoietic stem cell transplantation survivors: a controlled study.Lung, CNS and musculo-skeletal targeted therapy-induced toxicity: imaging features.A New Approach for Loading Anticancer Drugs Into Mesenchymal Stem Cell-Derived Exosome Mimetics for Cancer TherapyIndibulin dampens microtubule dynamics and produces synergistic antiproliferative effect with vinblastine in MCF-7 cells: Implications in cancer chemotherapyComplications neurologiques des traitements anticancéreux
P2860
Q27690249-71E9CBB2-6ECD-41CC-ABEF-28B18E065FF5Q33408049-24B220DA-9313-43F4-AFF7-0E67BFAFAD49Q35596252-058CACE3-0A6A-4A74-B5B4-B2EDAE0CB648Q35600122-0D3817B1-5516-4088-8351-E3C7EBCF2A8EQ36799814-D1AE2432-AD6E-4103-9AAA-5F6D91A0731FQ38062793-858179BC-06BD-4960-8C63-6FEB9B0F0B23Q38224422-BF2FC9D6-D834-49E3-BECB-675AE7C153A1Q38254351-017BFDD2-354A-4219-BCC7-CA8A713A9755Q38827940-F5552B7A-D8C8-4AA9-A0A1-CA9F4E85724BQ42361419-E13BD4EE-36AB-4F96-A89F-BC5F9AC1EB72Q42379481-63EEA9FB-CC89-4952-9AAC-DA44E22125F5Q43130009-B64C3B3B-9850-489B-BE88-720C5F854957Q45978314-B3BB5372-6CB6-470B-A120-AFB68125CCA0Q48854894-AB44F358-C91C-4FB6-8125-D48EA1CE1746Q50529617-972FFD78-ECC6-404B-8F99-E34E054FEF2EQ51497106-2CA1D565-B058-499E-8E89-48E05B8ACE1DQ55380706-6D12985A-78A7-4148-85FE-F8D1ACEAAF45Q57491566-3612AA7B-A47A-44CB-BFC9-3CC7E2C0F1EEQ58771071-877DDE29-7E49-49AA-99EB-477A6E1B41D3Q58929158-3AF910D6-1CE7-4BD4-93D2-62E82E8634B0
P2860
Neurological adverse effects caused by cytotoxic and targeted therapies.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Neurological adverse effects caused by cytotoxic and targeted therapies.
@ast
Neurological adverse effects caused by cytotoxic and targeted therapies.
@en
type
label
Neurological adverse effects caused by cytotoxic and targeted therapies.
@ast
Neurological adverse effects caused by cytotoxic and targeted therapies.
@en
prefLabel
Neurological adverse effects caused by cytotoxic and targeted therapies.
@ast
Neurological adverse effects caused by cytotoxic and targeted therapies.
@en
P2860
P1476
Neurological adverse effects caused by cytotoxic and targeted therapies
@en
P2093
David Schiff
Patrick Y Wen
P2860
P304
P356
10.1038/NRCLINONC.2009.128
P407
P577
2009-08-25T00:00:00Z